Lauriero F, Vita C, Perazzolo A, Sanseverino G, Moliterno E, Rovere G
Echocardiography. 2025; 42(2):e70099.
PMID: 39963997
PMC: 11834149.
DOI: 10.1111/echo.70099.
Ma H, Wang Y, Jia Y, Xie L, Liu L, Zhang D
Front Med (Lausanne). 2025; 11():1507313.
PMID: 39845823
PMC: 11750821.
DOI: 10.3389/fmed.2024.1507313.
Zamarra G, Sandu M, Caione N, Di Pasquale G, Di Berardino A, Di Ludovico A
J Clin Med. 2024; 13(22).
PMID: 39597824
PMC: 11594867.
DOI: 10.3390/jcm13226682.
Senigarapu S, Driscoll J
Front Med (Lausanne). 2024; 11:1477988.
PMID: 39540049
PMC: 11557331.
DOI: 10.3389/fmed.2024.1477988.
Edbom F, Lindqvist P, Wiklund U, Pilebro B, Anan I, Flachskampf F
Eur Heart J Imaging Methods Pract. 2024; 2(3):qyae100.
PMID: 39530018
PMC: 11551613.
DOI: 10.1093/ehjimp/qyae100.
Amyloid Goiter, Papillary Thyroid Carcinoma, and Diffuse Thyroid Lipomatosis: A Case Report of a Rare Association.
Vaz de Assuncao G, Fonseca L, Brandao J, Couto de Carvalho A, Freitas C
Cureus. 2024; 16(10):e71245.
PMID: 39525182
PMC: 11550454.
DOI: 10.7759/cureus.71245.
Localized amyloidoma of the chest wall: diagnostic and surgical perspectives.
Kawakami T, Atsumi J, Shimoda K, Hiramatsu M, Oka T, Shiraishi Y
Gen Thorac Cardiovasc Surg Cases. 2024; 2(1):24.
PMID: 39516904
PMC: 11533439.
DOI: 10.1186/s44215-023-00045-2.
Clinical manifestations, diagnosis and treatment of hereditary fibrinogen Aα-chain renal amyloidosis: one case report and systematic review.
He L, Zhou J, Wang M, Chen J, Liu C, Shi J
Int Urol Nephrol. 2024; 57(2):517-533.
PMID: 39417966
PMC: 11772542.
DOI: 10.1007/s11255-024-04236-w.
Histopathological and Immunohistochemical Characteristics of Different Types of Cardiac Amyloidosis.
Gioeva Z, Mikhaleva L, Gutyrchik N, Volkov A, Popov M, Shakhpazyan N
Int J Mol Sci. 2024; 25(19.
PMID: 39408996
PMC: 11476653.
DOI: 10.3390/ijms251910667.
Analysis and insights of cardiac amyloidosis: novel perception of rare diseases in cardiology.
Huang H, Liu Y, Chen X, Guo H, Yin Y, Ding M
Am J Transl Res. 2024; 16(9):4534-4548.
PMID: 39398585
PMC: 11470321.
DOI: 10.62347/KXHZ6884.
Gallium-68 fibroblast activation protein inhibitor positron emission tomography in cardiovascular disease.
Mpanya D, Sathekge M, Klug E, Damelin J, More S, Hadebe B
Front Nucl Med. 2024; 3:1224905.
PMID: 39355018
PMC: 11440833.
DOI: 10.3389/fnume.2023.1224905.
Structural Basis for Monoclonal Antibody Therapy for Transthyretin Amyloidosis.
Chakrabartty A
Pharmaceuticals (Basel). 2024; 17(9).
PMID: 39338387
PMC: 11435174.
DOI: 10.3390/ph17091225.
Safety assessment of Tafamidis: a real-world pharmacovigilance study of FDA adverse event reporting system (FAERS) events.
Li Y, Sun S, Wu H, Zhao L, Peng W
BMC Pharmacol Toxicol. 2024; 25(1):71.
PMID: 39334280
PMC: 11438280.
DOI: 10.1186/s40360-024-00790-2.
Exploring the Potential Long-term Impact of SARS-CoV-2 on Protein Misfolding and Amyloid-related Conditions.
Rashid M, Singha S, Arshad F, Sen P
Protein Pept Lett. 2024; 31(8):602-610.
PMID: 39253910
DOI: 10.2174/0109298665333817240821111641.
First report of the clinical characteristics and outcomes of cardiac amyloidosis in Saudi Arabia.
Ahmad O, Omer M, Janjua M, Alayary I, Fathala A, Alsergani H
ESC Heart Fail. 2024; 11(6):4348-4359.
PMID: 39219298
PMC: 11631269.
DOI: 10.1002/ehf2.15045.
A Systematic Review on Advances in Management of Oxidative Stress-Associated Cardiovascular Diseases.
Jin S, Kang P
Antioxidants (Basel). 2024; 13(8).
PMID: 39199169
PMC: 11351257.
DOI: 10.3390/antiox13080923.
Examining the Difficulties in Identifying and Handling Cardiac Amyloidosis; Acquiring Important Knowledge and Robust Treatment Methods.
Ali G, Seme W, Dudhat K
Cardiovasc Hematol Disord Drug Targets. 2024; 24(2):65-82.
PMID: 39075963
DOI: 10.2174/011871529X301954240715041558.
Impact of Anemia on Mortality and Morbidity in Transthyretin Amyloid Cardiomyopathy.
Wardhere A, Bampatsias D, Mirabal-Santos A, Weinsaft A, Guadalupe S, De Los Santos J
Am J Cardiol. 2024; 228:70-77.
PMID: 39067579
PMC: 11381150.
DOI: 10.1016/j.amjcard.2024.07.020.
Advancing Renal Amyloidosis Care: The Role of Modern Diagnostic Techniques with the Potential of Enhancing Patient Outcomes.
Delrue C, Dendooven A, Vandendriessche A, Speeckaert R, De Bruyne S, Speeckaert M
Int J Mol Sci. 2024; 25(11).
PMID: 38892061
PMC: 11172584.
DOI: 10.3390/ijms25115875.
The Promising Role of Selenium and Yeast in the Fight Against Protein Amyloidosis.
Kieliszek M, Sapazhenkava K
Biol Trace Elem Res. 2024; 203(3):1251-1268.
PMID: 38829477
PMC: 11872778.
DOI: 10.1007/s12011-024-04245-x.